Surgery in Metastatic Seminoma: Negative Trial Should Be Treated as Negative
- 20 November 2023
- journal article
- letter
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 41 (33) , 5202-5203
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal LymphadenopathyJournal of Clinical Oncology, 2023
- Single-dose carboplatin followed by involved-node radiotherapy for stage IIA and stage IIB seminoma (SAKK 01/10): a single-arm, multicentre, phase 2 trialThe Lancet Oncology, 2022
- Management of Seminomatous Testicular Cancer: A Binational Prospective Population-Based Study From the Swedish Norwegian Testicular Cancer Study GroupJournal of Clinical Oncology, 2011